Amyloid angiopathy-associated
intracerebral hemorrhage (ICH) comprises 12%-15% of lobar ICH in the elderly. This growing population has an increasing incidence of thrombolysis-related
hemorrhages, causing the management of
hemorrhages associated with
cerebral amyloid angiopathy (CAA) to take center stage. A concise reference assimilating the pathology and management of this clinical entity does not exist.
Amyloid angiopathy-associated
hemorrhages are most often solitary, but the natural history often progresses to include multifocal and recurrent
hemorrhages. Compared with other causes of ICH, patients with CAA-associated
hemorrhages have a lower mortality rate but an increased risk of recurrence. Unlike hypertensive arteriolar
hemorrhages that occur in penetrating subcortical vessels, CAA-associated
hemorrhages are superficial in location due to preferential involvement of vessels in the cerebral cortex and meninges. This feature makes CAA-associated
hemorrhages easier to access surgically. In this paper, the authors discuss 3 postulates regarding the pathogenesis of
amyloid hemorrhages, as well as the established clinicopathological classification of
amyloid angiopathy and CAA-associated ICH. Common inheritance patterns of familial CAA with
hemorrhagic strokes are discussed along with the role of genetic screening in relatives of patients with CAA. The radiological characteristics of CAA are described with specific attention to CAA-associated microhemorrhages. The detection of these microhemorrhages may have important clinical implications on the administration of anticoagulation and antiplatelet
therapy in patients with probable CAA. Poor patient outcome in CAA-associated ICH is associated with
dementia, increasing age,
hematoma volume and location, initial Glasgow Coma Scale score, and intraventricular extension. The surgical management strategies for
amyloid hemorrhages are discussed with a review of published surgical case series and their outcomes with a special attention to
postoperative hemorrhage.